These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
445 related articles for article (PubMed ID: 21615150)
1. Progress in structure based drug design for G protein-coupled receptors. Congreve M; Langmead CJ; Mason JS; Marshall FH J Med Chem; 2011 Jul; 54(13):4283-311. PubMed ID: 21615150 [No Abstract] [Full Text] [Related]
2. Allosteric drugs and seven transmembrane receptors. Kenakin T Curr Top Med Chem; 2013; 13(1):5-13. PubMed ID: 23409762 [TBL] [Abstract][Full Text] [Related]
3. Applying Structure-Based Drug Design Approaches to Allosteric Modulators of GPCRs. Congreve M; Oswald C; Marshall FH Trends Pharmacol Sci; 2017 Sep; 38(9):837-847. PubMed ID: 28648526 [TBL] [Abstract][Full Text] [Related]
4. G-protein-coupled receptors in drug discovery--seventh annual Informa conference. Part 1--GPCR structures and ligand binding. Jockers R IDrugs; 2009 May; 12(5):285-8. PubMed ID: 19431090 [No Abstract] [Full Text] [Related]
5. Allosteric modulation as a unifying mechanism for receptor function and regulation. Changeux JP; Christopoulos A Diabetes Obes Metab; 2017 Sep; 19 Suppl 1():4-21. PubMed ID: 28880476 [TBL] [Abstract][Full Text] [Related]
7. Novel Allosteric Modulators of G Protein-coupled Receptors. Gentry PR; Sexton PM; Christopoulos A J Biol Chem; 2015 Aug; 290(32):19478-88. PubMed ID: 26100627 [TBL] [Abstract][Full Text] [Related]
8. Allosteric modulation of G protein-coupled receptors: perspectives and recent developments. Soudijn W; Van Wijngaarden I; IJzerman AP Drug Discov Today; 2004 Sep; 9(17):752-8. PubMed ID: 15450241 [TBL] [Abstract][Full Text] [Related]
9. Allosteric Modulation as a Unifying Mechanism for Receptor Function and Regulation. Changeux JP; Christopoulos A Cell; 2016 Aug; 166(5):1084-1102. PubMed ID: 27565340 [TBL] [Abstract][Full Text] [Related]
10. Structural basis for modulation of a G-protein-coupled receptor by allosteric drugs. Dror RO; Green HF; Valant C; Borhani DW; Valcourt JR; Pan AC; Arlow DH; Canals M; Lane JR; Rahmani R; Baell JB; Sexton PM; Christopoulos A; Shaw DE Nature; 2013 Nov; 503(7475):295-9. PubMed ID: 24121438 [TBL] [Abstract][Full Text] [Related]
11. Emerging paradigms in GPCR allostery: implications for drug discovery. Wootten D; Christopoulos A; Sexton PM Nat Rev Drug Discov; 2013 Aug; 12(8):630-44. PubMed ID: 23903222 [TBL] [Abstract][Full Text] [Related]
12. Emerging Paradigm of Intracellular Targeting of G Protein-Coupled Receptors. Chaturvedi M; Schilling J; Beautrait A; Bouvier M; Benovic JL; Shukla AK Trends Biochem Sci; 2018 Jul; 43(7):533-546. PubMed ID: 29735399 [TBL] [Abstract][Full Text] [Related]
15. The best of both worlds? Bitopic orthosteric/allosteric ligands of g protein-coupled receptors. Valant C; Robert Lane J; Sexton PM; Christopoulos A Annu Rev Pharmacol Toxicol; 2012; 52():153-78. PubMed ID: 21910627 [TBL] [Abstract][Full Text] [Related]
16. Analysis of tractable allosteric sites in G protein-coupled receptors. Wakefield AE; Mason JS; Vajda S; Keserű GM Sci Rep; 2019 Apr; 9(1):6180. PubMed ID: 30992500 [TBL] [Abstract][Full Text] [Related]
17. Allosteric modulation of kinases and GPCRs: design principles and structural diversity. Lewis JA; Lebois EP; Lindsley CW Curr Opin Chem Biol; 2008 Jun; 12(3):269-80. PubMed ID: 18342020 [TBL] [Abstract][Full Text] [Related]